Supportive care intervention for patients with locally advanced rectal cancer
Official title: PATHWAYS: An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
Run by Massachusetts General Hospital · NCT05914766 · Data updated 2026-11-12
This study is testing a new support program to help patients with locally advanced rectal cancer feel more confident and informed as they start their treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 2 sites (Boston, Massachusetts and 1 other locations) |
| Status | Recruiting |
| Started | September 21, 2023 |
| Main results expected | May 21, 2028 |
| Study ends | December 2028 |
| Registry record updated | October 9, 2026 |
| Trial ID | NCT05914766 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are newly diagnosed with locally advanced rectal cancer and are within 8 weeks of deciding to pursue multimodality therapy.
✕Probably not a fit
Patients with comorbid health conditions that interfere with study participation or those who have previously been treated for colorectal cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility and acceptability of a psychoeducational intervention designed to enhance self-efficacy in patients with locally advanced rectal cancer who are starting multimodality treatment. It consists of two phases, with the first phase testing the intervention on a small group of participants. The second phase will expand the participant pool to assess the refined intervention's effectiveness compared to standard care. Participants in the intervention group will receive coaching sessions focused on treatment-related information and support.
Why it matters
Potential benefit: If successful, this intervention could significantly improve patients' self-efficacy and quality of life during their treatment for rectal cancer.
How similar studies have gone: Other studies have shown promise in using psychoeducational interventions to support cancer patients, indicating that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age≥18 years 2. Within 8 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease) 3. Able to complete study procedures English or with the assistance of an interpreter Exclusion Criteria: 1. Comorbid health condition that would interfere with study participation, as identified by cancer care team 2. Has undergone treatment for a prior colorectal cancer
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting -
Dana-Farber Cancer Institute
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Kelsey Lau-Min, MD, MSCE — Massachusetts General Hospital
- Study coordinator: Kelsey Lau-Min, MD, MSCE
- Email: klau-min@mgh.harvard.edu
- Phone: 617-724-4000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single vs. double stapling and purse-string techniques after rectal cancer surgery
This trial tests whether using a single-stapling method to join the bowel after rectal cancer surgery results in fewer leaks compared with the double-stapling method.
-
Digital storytelling-based psychoeducation to ease loneliness and boost self-efficacy in adults aged 65–74
The study tests whether a digital storytelling–based psychoeducation program can reduce loneliness and improve self-efficacy in adults 65 to 74 who participate in the program versus a comparison group.
-
Sleep Better, Live Better: a 12-week coaching program to help adults improve sleep and heart-brain health
This trial tests a 12-week, telephone- and text-based sleep coaching program for adults 25–65 with short sleep and higher cardiometabolic risk to see if it improves sleep and related behaviors.
-
DEM301 in advanced colorectal cancer: a first-in-human test
This first-in-human Phase 1 study tests DEM301 in adults with advanced metastatic colorectal cancer to see if it is safe, how it behaves in the body, and whether it shows any signs of activity.
-
Rectal cancer registry to track real-world treatments and outcomes
This registry collects real-world data on how locally advanced rectal cancer is treated in Austria, to see how TNT and dMMR/MSI-H cases are managed and what outcomes occur.
-
Aerobic exercise and guided imagery for bowel problems after rectal cancer surgery
This study tests whether a program of aerobic exercise plus guided imagery helps people with low anterior resection syndrome after rectal cancer surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.